Certain active agents (so-called targeted therapies) are directed against characteristic features of the tumour. It is only if the tumour has these characteristics that the patient could benefit from the targeted therapy. maintrac® allows characterisation of the therapeutically-relevant features of the CETCs currently present in the blood.

The following table shows some additional investigations that can be carried out with the CETCs from the blood sample.  

Eigenschaften, simfo, maintrac,Publikationen, Hormontherapie, CETC, Tumorzellen
Akzeptieren Durch die weitere Nutzung der Seite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen